Hayfin Supports Crown Lab GlaxoSmithKline Brands Acquisition

Hayfin Capital Management provided debt financing to support Crown Laboratories and Hildred Capital Partners’ acquisition of North American distribution rights of five OTC consumer brands from GlaxoSmithKline.

Sage Group Advises Vita Liberata in Its Sale to Crown Lab

The Sage Group, an independent investment bank which provides corporate finance advice to consumer and beauty companies, served as the exclusive financial advisor to Vita Liberata in its sale to Crown Laboratories.